A new research has suggested how our immune system might be working against us. Our Immune cells help cancer thrive in our body instead of trying to eradicate it. The immune system is essentially our…
Immune Cells Help Cancer Thrive Instead Of Fighting It
A new research has suggested how our immune system might be working against us. Our Immune cells help cancer thrive in our body instead of trying to eradicate it. The immune system is essentially our body’s private security detail. It’s a complex network of cells, tissues, as well as organs that work in sync to defend us against “invaders” like bacteria, viruses, fungi, and even our own cells if they turn cancerous.
White blood cells are a part of immune system. They usually protect our body from harm. One specific type is called the neutrophil. These cells act like first responders to infections. They rush to the site of an injury. They kill germs and keep you healthy. At first, scientists thought they always fought cancer too. But, new research shows a different story. In reality, some neutrophils change their behavior. They stop fighting and start helping the tumor. This process is a form of deleterious reprogramming. The immune cells help cancer by becoming double agents. They actively promote tumor growth instead of stopping it.
The Mystery Molecule CCL3
Researchers studied how these cells change over time. At the present time, we know they produce a molecule called CCL3. This protein is a chemokine. To illustrate, think of it as a signal. Aged neutrophils produce high levels of CCL3. This happens most often in hypoxic areas of the tumor. These are spots with very little oxygen. To point out, the tumor environment is very harsh. Provided that the cells produce CCL3, they can survive there. This molecule ensures that immune cells help cancer cells survive. What’s more, it encourages the cancer to expand. Summing up, the protein creates a safe zone for the disease.
New Research Shows How These Immune Cells Help Cancer Survive
Every tumor has a unique biological signature. Scientists call this a tumor identity card. To explain, this card helps doctors predict disease progression. The study looked at over 190 different tumors. As a result, they found a common pattern. CCL3 appears in many types of cancer. At this point, it serves as a biomarker. Doctors can measure it to see how aggressive a cancer is. To put it differently, it acts like a warning light. In short, finding this molecule helps track the illness. It shows how these immune cells help cancer spread.
Engineering the Future of Medicine
This discovery opens new doors for STEM careers. Prior to this study, we lacked these specific targets. To be sure, we need new tools to stop CCL3. This is where bioinformatics and biomedical engineering come in. You could design better drugs in the future by understanding how immune cells help cancer progress and how this interaction can be disrupted. At any rate, the demand for STEM education is growing. You can learn about Engineering Branches Explained to see your options. In similar fashion, you might explore a Career in STEM Education to lead research. So that you can help, start building your skills now. All in all, science needs your curiosity and talent.
STEM Career & Research Roles
- Cancer Biologist: Studying how cancer cells send signals (cytokines) to “reprogram” macrophages into “M2” (pro-tumor) states.
- Bioinformatician: Using Single-Cell RNA Sequencing to map which immune cells are “helping” the tumor vs. which are trying to fight it.
- Pharmacologist: Developing “checkpoint inhibitors” or drugs that “re-educate” immune cells to turn back into defenders.
- Bioengineer: Creating “Tumor-on-a-Chip” models to simulate how immune cells migrate into a tumor and change their behavior.
Additionally, to stay updated with the latest developments in STEM research, visit ENTECH Online. Basically, this is our digital magazine for science, technology, engineering, and mathematics. Also, at ENTECH Online, you’ll find a wealth of information.
References
Bolli, E., Wirapati, P., Hicham, M., Xie, Y., Siwicki, M., Duval, F., … & Pittet, M. J. (2026). CCL3 is produced by aged neutrophils across cancers and promotes tumor growth. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.01.006
- Author
- Latest Posts
A Master’s-qualified Zoologist with a focus on Limnology, I combine hands-on laboratory experience with a sophisticated background in science communication. My career is defined by an interdisciplinary approach to the life sciences, merging technical research skills with a proven ability to teach and engage diverse audiences. I am committed to lifelong learning and the creative dissemination of medical and biological research, ensuring scientific literacy and inspiration remain at the forefront of the field.
